Medicare Enrolled
Dr. Orville McLenan, MD
Urology Physician · Freeport, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McLenan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McLenan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McLenan
Dr. Orville McLenan is an urology physician in Freeport, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. McLenan performed 3,422 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McLenan received a total of $6,435 from 30 pharmaceutical and/or device companies across 212 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McLenan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 25% volume in NY
$6,435 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,422
Medicare services
Top 25% in NY for urology physician
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
628 | $3 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
482 | $110 | $441 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
356 | $8 | $24 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
330 | $75 | $307 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
231 | $8 | $9 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
127 | $10 | $49 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
126 | $8 | $26 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
118 | $79 | $291 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
117 | $47 | $172 |
| PSA test (prostate cancer screening) | 116 | $18 | $55 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 96 | $87 | $505 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
89 | $10 | $32 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
85 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
85 | $8 | $24 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
77 | $13 | $49 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
63 | $122 | $454 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $134 | $579 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
48 | $0 | $3 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
47 | $25 | $77 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $30 | $121 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
28 | $83 | $394 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
27 | $5 | $14 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
26 | $237 | $975 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
22 | $74 | $270 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
16 | $18 | $55 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,435
Total received (2018-2024)
Avg $919/year across 7 years
Top 26% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
212
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$953
2023
$587
2022
$726
2021
$507
2020
$304
2019
$2,506
2018
$852
Payments by company (2024)
Astellas Pharma US Inc
$298
Janssen Biotech, Inc.
$99
Sumitomo Pharma America, Inc.
$96
COLOPLAST CORP
$68
Tolmar, Inc.
$65
Teleflex LLC
$59
Dendreon Pharmaceuticals LLC
$51
Telix Pharmaceuticals
$43
Bayer Healthcare Pharmaceuticals Inc.
$37
Verity Pharmaceuticals Inc.
$35
Calyxo, Inc.
$32
Endo Pharmaceuticals Inc.
$25
AstraZeneca Pharmaceuticals LP
$24
Ferring Pharmaceuticals Inc.
$20
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$2,159
Endo Pharmaceuticals Inc.
$729
Janssen Biotech, Inc.
$690
Astellas Pharma US Inc
$573
Boston Scientific Corporation
$499
Dendreon Pharmaceuticals LLC
$306
Sumitomo Pharma America, Inc.
$192
Teleflex LLC
$160
PFIZER INC.
$113
COLOPLAST CORP
$102
UROVANT SCIENCES INC
$98
Verity Pharmaceuticals Inc.
$92
BOSTON SCIENTIFIC CORPORATION
$92
Myovant Sciences Inc.
$83
Tolmar, Inc.
$82
Bayer HealthCare Pharmaceuticals Inc.
$79
Bayer Healthcare Pharmaceuticals Inc.
$62
Amgen Inc.
$55
Telix Pharmaceuticals
$43
TOLMAR Pharmaceuticals, Inc.
$36
Calyxo, Inc.
$32
HOLOGIC INC
$26
AstraZeneca Pharmaceuticals LP
$24
UroGen Pharma, Inc.
$23
Ferring Pharmaceuticals Inc.
$20
Myriad Genetic Laboratories, Inc.
$16
Antares Pharma, Inc.
$13
Blue Earth Diagnostics Limited
$12
Janssen Pharmaceuticals, Inc
$12
Endocare, Inc.
$11
Top 3 companies account for 55.6% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ALTIS · AMS · AVEED · Axumin · CVAC ASPIRATION SYSTEM · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL - BPH · GENERAL BPH · ILLUCCIX · JATENZO · JELMYTO · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · PROVENGE · Prolaris · REZUM · SPEEDICATH · TITAN · Titan · Trelstar · UROLIFT · Ultrasound · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
574
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI SOUTH NASSAU
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McLenan is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McLenan experienced with urinalysis, manual?
Based on Medicare claims data, Dr. McLenan performed 628 urinalysis, manual services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McLenan receive payments from pharmaceutical companies?
Yes. Dr. McLenan received a total of $6,435 from 30 companies across 212 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McLenan's costs compare to other urology physicians in Freeport?
Dr. McLenan's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McLenan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Freeport
Browse urology physicians in Freeport ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology